EXAS Stock News 12.68 05/13/2014 16:31:52 Exact Sciences Corp

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Exact Sciences Corp (EXAS) 12.68 $EXAS

Earnings Look Back: Exact Sciences Is Down 5.4% Since Reporting Quarterly Results 1 Week Ago (EXAS)
Comtex SmarTrend(R) - Mon May 12, 11:45AM CDT
When Exact Sciences (NASDAQ:EXAS) reported earnings a week ago on May 1st, 2014, analysts, on average, expected the company to report a loss of $0.19 on sales of $831.0 thousand. The company actually reported a loss of $0.23 per share on sales of $294.0 thousand, missing EPS estimates by $0.04 and missing revenue estimates by $0.5 million. Since the company's report, shares of Exact Sciences have fallen from $12.56 to $11.88, representing a loss of 5.4% in the past 11 days.

2014 FDA Drug Approval Calendar
at The Street - Mon May 12, 8:22AM CDT
A list of drugs under FDA review and scheduled FDA advisory panel meetings.

Technical Data on Biotech Stocks -- Research on Exact Sciences, Amgen, Exelixis, and Incyte
PR Newswire - Tue May 06, 8:57AM CDT
On Monday, May 05, 2014, the NASDAQ Composite ended at 4,138.06, up 0.34%, the Dow Jones Industrial Average finished the day 0.11% higher at 16,530.55, and the S&P 500 closed at 1,884.66, up 0.19%. The gains were broad based as eight out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 672.57, up 0.56%, and the index has advanced 0.12% in the last one month. Investor-Edge has initiated coverage on the following equities: Exact Sciences Corporation (NASDAQ: EXAS), Amgen Inc (NASDAQ: AMGN), Exelixis Inc. (NASDAQ: EXEL) and Incyte Corp. Ltd (NASDAQ: INCY). Free technical research on EXAS, AMGN, EXEL and INCY can be downloaded upon signing up at:

Released and Scheduled Earnings Results - Analyst Notes on Pacira, Exact Sciences, Synageva, Agios and Vanda Pharmaceuticals
PR Newswire - Tue May 06, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Pacira Pharmaceuticals Inc. (NASDAQ: PCRX), Exact Sciences Corporation (NASDAQ: EXAS), Synageva BioPharma Corp. (NASDAQ: GEVA), Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) and Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2054-100free.

Exact Sciences to Participate in May Investor Conferences
Business Wire - Mon May 05, 7:02AM CDT
Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will participate in two investor conferences during May.

Why EXACT Sciences Corporation Shares Briefly Tumbled
Sean Williams, The Motley Fool - Motley Fool - Thu May 01, 3:32PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of EXACT Sciences , a molecular diagnostics...

Why You Should Watch Merrimack, Exact Sciences, and Incyte Today
George Budwell, The Motley Fool - Motley Fool - Thu May 01, 8:10AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Exact Sciences , Incyte Corporation and Merrimack Pharmaceuticals .  Exact Sciences misses on earnings and revenue Exact Sciences posted a wider loss...

Exact Sciences Reports First-Quarter 2014 Financial Results
Business Wire - Thu May 01, 6:31AM CDT
Exact Sciences Corp. (Nasdaq: EXAS) today announced its financial results for the quarter March 31, 2014.

Exact Sciences to Host First-Quarter 2014 Results Webcast and Call
Business Wire - Fri Apr 25, 8:00AM CDT
Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host a webcast and conference call to discuss its first-quarter 2014 financial results on May 1, 2014.

Exact Sciences Falls 3.86% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Apr 14, 6:02PM CDT
Exact Sciences (NASDAQ:EXAS) traded in a range yesterday that spanned from a low of $11.51 to a high of $12.76. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $12.25 on volume of 2.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Exact Sciences Announces Successful Completion of Public Offering of Common Stock
Business Wire - Wed Apr 09, 3:05PM CDT
Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its previously announced underwritten public offering of its common stock at a price of $12.75 per share to the public.

Stocks Review on Top Gainers -- Research on Genco Shipping & Trading, Exact Sciences, Baltic Trading, and Eagle Bulk Shipping
PR Newswire - Mon Apr 07, 11:38AM CDT
The US markets saw a negative sentiment on Friday, April 4, 2014, with the NASDAQ Composite closing at 4,127.73, down 2.60%, the Dow Jones Industrial Average ending the session at 16,412.71, down 0.96%, and the S&P 500 declining 1.25% to finish the trading session at 1,865.09. The session witnessed selling pressure in the Information Technology, Consumer Discretionary, Health Care, and Materials sectors that negatively impacted the broader market. A number of stocks saw large movements, including Genco Shipping & Trading Ltd (NYSE: GNK), Exact Sciences Corp. (NASDAQ: EXAS), Baltic Trading Ltd (NYSE: BALT) and Eagle Bulk Shipping Inc. (NASDAQ: EGLE). Free technical research on GNK, EXAS, BALT and EGLE can be downloaded upon signing up at:

Nasdaq stocks posting largest percentage increases
AP - Fri Apr 04, 5:20PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

Why Exact Sciences (EXAS) Stock Is Higher On Friday
at The Street - Fri Apr 04, 8:56AM CDT
Shares of Exact Sciences (EXAS) are up 5.30% to $13.60 after the molecular diagnostics company announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a price of $12.75 per share to the public.

Exact Sciences Prices Public Offering of Common Stock
Business Wire - Fri Apr 04, 7:42AM CDT
Exact Sciences Corp. (NASDAQ: EXAS) today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a price of $12.75 per share to the public. The net proceeds to Exact from this offering are expected to be approximately $119.7 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by Exact. The offering is expected to close on or about April 9, 2014, subject to the satisfaction of customary closing conditions. Exact has granted the underwriters a 30-day option to purchase up to an aggregate of 1,500,000 additional shares of common stock. Exact anticipates using the net proceeds from the offering to fund its efforts to obtain FDA approval of its Cologuard test, to fund Cologuard commercialization activities, to fund product development efforts, and for general corporate and working capital purposes.

Exact Sciences (EXAS) Jumps: Stock Adds 10.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 7:51AM CDT
Exact Sciences Corporation was a big mover last session, as its shares rose over 10% on the day.

Why Exact Sciences, Builders FirstSource, and Clayton Williams Energy Jumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Mon Mar 31, 7:00PM CDT
Over the weekend, investors who tuned into 60 Minutes got a look at the new Michael Lewis book on high-frequency trading, with dire conclusions about how traders take advantage of both institutional and individual investors. Yet even with that...

Today's Dead Cat Bounce Stock Is Exact Sciences Corporation (EXAS)
at The Street - Mon Mar 31, 8:45AM CDT
Trade-Ideas LLC identified Exact Sciences Corporation (EXAS) as a "dead cat bounce" (down big yesterday but up big today) candidate

CBS Outdoor Americas Climbs on First Day of Trading; FDA Advisory Panel Recommends Approval of Exact Sciences Corporation's Cologuard
ACCESSWIRE - Sun Mar 30, 11:16PM CDT
CBS Outdoor Americas Inc. (NYSE: CBSO) - For an in-depth report on CBS Outdoor Americas Inc. follow: www.BullTrends.com/stockquote/CBSO

'Mad Money' Lightning Round: Sell Starbucks at $72
at The Street - Sat Mar 29, 5:00AM CDT
Cramer prefers Boeing over AerCap Holdings and CBS Outdoor over Chambers Street Properties.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 45

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
Monotype Unveils Font Tool for Adobe: A Game-Changer?

Updated Category News Views 106

Monotype Connect: Fonts Meet Convenience Imagine fighting through a blizzard with a flashlight. That's how designers juggle fonts without a central tool. Well, Monotype's got them covered with the new Connect panel for Adobe apps—a beacon of efficiency spotted at Adobe MAX 2026 in Miami Beach. Efficiency and Brand Unity: Partners in Design Now, here’s why this isn’t...

Continue Reading
Home Energy Tips: Embrace the Electrical Panel Shift

Updated Category News Views 52

Why Electrical Panels Matter More Than Ever Back in the day, electrical panels weren't exactly the star of the homeowner show. But times have changed, and those previously mundane boxes of switches and wires now demand a spotlight. Shifts in modern lifestyles have catapulted electrical systems into the spotlight, making upgrades a pressing conversation topic for savvy...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 39

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Panasonic Showcases Rugged Tech at NATO Edge 26

Updated Category News Views 56

Panasonic Heads to Turkey with Tactical Tech Panasonic's got its sights set on proving a point at NATO Edge 26, busting out its TOUGHBOOK line and showing just how these rugged laptops aren't just tough, but also strategically essential. From November 17th through 19th, down in Turkey, these devices are taking the spotlight as they embrace the operational challenges of...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 111

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
HLTH USA 2026 Spotlights AI and Health Innovation

Updated Category News Views 77

The Pulse of Innovation at HLTH USA 2026 Diving headfirst into the heart of healthcare innovation, HLTH USA 2026 kicked off with gusto in Las Vegas. Discussions are swirling around AI advancements and the next generation of payer-provider collaboration. Who knew healthcare could be this thrilling? The event is already shaping up to be a powerhouse of change, buzzing with...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 148

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 45

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 83

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading

Top 5 Most Recently Viewed Articles

Blain’s Farm & Fleet Shines in Newsweek’s Best Online Shops

Updated Category News Views 97

Blain’s Farm & Fleet Achieves Recognition for Online Excellence Blain's Farm & Fleet, a well-respected name in retail, has been honored as one of Newsweek’s Best Online Shops for 2025. This recognition marks the fourth consecutive year the company has earned this prestigious title, reflecting its unwavering commitment to quality and service across its online platform....

Continue Reading
Statkraft AS Secures NOK 3 Billion Through Commercial Paper

Updated Category News Views 127

Statkraft AS Secures Significant Funding Statkraft AS has successfully issued a commercial paper totaling NOK 3.0 billion, showcasing the company's strategic approach to financing. This financial instrument offers a coupon rate of 3M NIBOR plus 0.205%, reflecting favorable conditions in financial markets. Details of the Commercial Paper The commercial paper is designed...

Continue Reading
Soleno Therapeutics Launches $100 Million Stock Buyback Program

Updated Category News Views 143

Soleno Therapeutics Initiates Major Buyback Program Soleno Therapeutics Inc. (NASDAQ: SLNO) has announced a significant development in its corporate strategy by launching a $100 million share repurchase program. This move comes as the company seeks to enhance shareholder value amidst an environment where its stock has been deemed undervalued by market analysts. Details of...

Continue Reading
Brentwood Associates Launches $410 Million Fund for Watermill

Updated Category News Views 383

Overview of the New Continuation Fund Brentwood Associates, a leading private equity firm known for its strategic and growth-oriented investments, has officially closed an impressive $410 million continuation fund aimed at fueling the expansion of Watermill Express, LLC. This fund's purpose is to enhance the operational capabilities of Watermill Express, a prominent...

Continue Reading
Great Lakes Dredge & Dock Corporation Upgraded to B- Rating

Updated Category News Views 105

Great Lakes Dredge & Dock Corporation Receives S&P Upgrade Great Lakes Dredge & Dock Corporation ("Great Lakes" or the “Company”) (NASDAQ: GLDD), the leading provider of dredging services in the United States, has announced a notable upgrade to its issuer credit rating by S&P Global Ratings. The rating has been elevated from “CCC+” to “B-,” signaling a...

Continue Reading